Press Release: Silo Pharma Secures Patent that May be Used for Psychedelics Delivery Technology
Cannabis Law Report
AUGUST 22, 2021
Silo Pharma’s notice of allowance paves the way toward clinical trials for its psychedelics delivery platform using homing peptides. Presently, the company is working with researchers to build out these technologies and pave the way for clinical trials. Silo Pharma Inc. Looking to the Future. Silo Pharma Inc.
Let's personalize your content